{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "triggerable": false, "customPriceAlertConfidence": "LOW", "epsTrailingTwelveMonths": -3.504, "sharesOutstanding": 54711400, "bookValue": 0.998, "fiftyDayAverage": 5.7237744, "fiftyDayAverageChange": -3.7917743, "fiftyDayAverageChangePercent": -0.66246045, "twoHundredDayAverage": 9.133706, "twoHundredDayAverageChange": -7.201706, "twoHundredDayAverageChangePercent": -0.78847575, "marketCap": 473444, "priceToBook": 1.9358717, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "currency": "NOK", "financialCurrency": "NOK", "regularMarketOpen": 1.942, "averageDailyVolume3Month": 15470, "averageDailyVolume10Day": 11363, "fiftyTwoWeekLowChange": 0.17200005, "fiftyTwoWeekLowChangePercent": 0.0977273, "fiftyTwoWeekRange": "1.76 - 16.98", "fiftyTwoWeekHighChange": -15.047999, "fiftyTwoWeekHighChangePercent": -0.8862191, "fiftyTwoWeekLow": 1.76, "fiftyTwoWeekHigh": 16.98, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "firstTradeDateMilliseconds": 1513152000000, "priceHint": 4, "marketState": "POSTPOST", "regularMarketChange": 0.014000058, "regularMarketTime": 1683910620, "regularMarketDayHigh": 1.942, "regularMarketDayRange": "1.932 - 1.942", "regularMarketDayLow": 1.932, "regularMarketVolume": 5974, "regularMarketPreviousClose": 1.918, "bid": 0.0, "ask": 0.0, "fullExchangeName": "LSE", "regularMarketChangePercent": 0.72993004, "regularMarketPrice": 1.932, "exchangeTimezoneName": "Europe/London", "exchangeTimezoneShortName": "BST", "gmtOffSetMilliseconds": 3600000, "esgPopulated": false, "exchange": "LSE", "shortName": "BERGENBIO ASA BERGENBIO ORD SHS", "longName": "BerGenBio ASA", "messageBoardId": "finmb_107144331", "market": "gb_market", "symbol": "0RU5.L"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "M\u00f8llendalsbakken 9", "city": "Bergen", "zip": "5009", "country": "Norway", "phone": "47 53 50 15 64", "website": "https://www.bergenbio.com", "industry": "", "sector": "", "longBusinessSummary": "BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in development of drugs to treat immune evasive, drug resistant, and metastatic cancers; and respiratory diseases. Its lead candidate is Bemcentinib, an oral once-a-day inhibitor of AXL receptor tyrosine kinase, which is in Phase II clinical development that focuses on treatment of non-small cell lung cancer, acute myeloid leukaemia, and COVID-1. The company is also developing tilvestamab, an anti-AXL function-blocking monoclonal antibody that is in Phase Ib clinical trial. It has a collaboration agreement with Merck & Co. for clinical trials. The company was incorporated in 2007 and is based in Bergen, Norway.", "fullTimeEmployees": 29, "companyOfficers": [{"maxAge": 1, "name": "Mr. Martin  Olin", "age": 53, "title": "Chief Exec. Officer", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": {"raw": 879871, "fmt": "879.87k", "longFmt": "879,871"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Rune  Skeie", "age": 49, "title": "Chief Financial Officer", "yearBorn": 1973, "fiscalYear": 2022, "totalPay": {"raw": 2559000, "fmt": "2.56M", "longFmt": "2,559,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. James  Barnes Ph.D.", "title": "Chief Operating Officer", "fiscalYear": 2022, "totalPay": {"raw": 269000, "fmt": "269k", "longFmt": "269,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Nigel  McCracken M.Sc., Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2022, "totalPay": {"raw": 379973, "fmt": "379.97k", "longFmt": "379,973"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Gayle M. Mills M.B.A", "age": 67, "title": "Chief Bus. Officer", "yearBorn": 1955, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Cristina  Oliva M.D.", "title": "Chief Medical Officer", "fiscalYear": 2022, "totalPay": {"raw": 342507, "fmt": "342.51k", "longFmt": "342,507"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Akil  Jackson", "title": "Medical Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}